Related by context. All words. (Click for frequent words.) 76 PLK1 SNALP 71 PSMA ADC 70 IMA# 70 TKM ApoB 70 INCB# [001] 70 R#/MEM # 70 nalbuphine ER 69 ALN PCS 69 Solazed TM 69 TOCOSOL Paclitaxel 68 Azedra 68 IRX 2 68 MAXY G# 68 AEG# 68 TBC# 68 evaluating tivozanib 68 oral prodrug 68 SNALP technology 68 Solazed 68 TOCOSOL Camptothecin 67 EndoTAG TM -1 67 PNP inhibitor 67 CRD5 67 ALN VSP 67 elotuzumab 67 KNS # 67 metaglidasen 67 MAXY VII 67 TELINTRA 67 DOS# 66 HGS ETR1 66 mertansine 66 HQK 66 Bezielle 66 MEK inhibitor 66 RLY# 66 MYDICAR ® 66 Panzem R 66 Sym# 66 GRNVAC1 66 MEK inhibitor RDEA# 66 acyclovir Lauriad R 66 Myocet 66 Genasense ® oblimersen 66 targeted radiotherapeutic 66 polysaccharide polymer 66 liposomal formulation 66 ELACYT 66 Nanobody 66 AeroLEF TM 66 MAGE A3 ASCI 66 Interferon alpha 66 PDE4 inhibitor 66 Cleviprex TM clevidipine 66 generation antisense 66 Androxal TM 66 Azedra TM 66 candidate Zenvia 66 Phase #b/#a clinical 66 Zemiva TM 66 Mipomersen 65 RhuDex ® 65 PSN# [002] 65 forodesine 65 orally administered inhibitor 65 lomitapide 65 HuLuc# 65 therapeutic monoclonal antibody 65 SNALP formulation 65 CD# CEA 65 Genasense R oblimersen 65 Phase IIa trials 65 CCX# 65 investigational humanized monoclonal antibody 65 investigational monoclonal antibody 65 THR beta agonist 65 XOMA 3AB 65 dextofisopam 65 huC# DM4 65 Onconase 65 XmAb 65 immunotherapeutic agent 65 FluCide 65 PEG SN# 65 Protexia ® 65 JAK inhibitor 65 Phase 2a clinical trials 65 selective androgen receptor modulator 65 Panzem R NCD 65 Dapagliflozin 65 ALN TTR 65 HGS# 65 TKM PLK1 65 SinuNase ™ 65 PRT# 65 PEGPH# 65 anticancer compound 65 HGS ETR2 65 IL# PE#QQR 65 siRNA therapeutic 65 Stedivaze 65 BCX# 65 indibulin 65 JAK2 inhibitor 65 Onco TCS 64 thymalfasin 64 alvespimycin 64 Prodarsan ® 64 cancer immunotherapies 64 TLK# 64 candidate XP# 64 Archexin 64 RDEA# 64 Zingo TM 64 Personalized Immunotherapy 64 HspE7 64 nucleotide analog 64 Veronate 64 HCV protease inhibitor 64 Chrysalin 64 VitiGam 64 Allovectin 7 64 Phase IIb clinical trials 64 SinuNase TM 64 ISIS # 64 OncoVEX GM CSF 64 vosaroxin 64 PORxin TM 64 liprotamase 64 BiTE antibody 64 phase IIa clinical 64 GSK# [002] 64 Ophena TM 64 Asentar 64 Azedra ™ 64 ostarine 64 OvaRex R 64 stable nucleic acid 64 Trofex TM 64 custirsen 64 Troxatyl 64 CEQ# 64 ALV# 64 JAK1 64 Chemophase 64 MOZOBIL 64 CIMZIA ™ 64 Generx TM 64 CCR5 mAb 64 LY# [003] 64 PORxin TM platforms 64 Elotuzumab 64 EOquin 64 inhaled liposomal ciprofloxacin 64 standard chemotherapy regimen 64 phase IIb clinical 64 Xcytrin R 64 Symadex 64 lintuzumab SGN 64 Alocrest 64 Anturol ® 64 synthetic retinoid 64 sorafenib tablets 64 CORT # 64 CTAP# Capsules 64 PS# [001] 64 novel VDA molecule 63 GVAX ® 63 CBLC# 63 paclitaxel Taxol ® 63 Xcellerated T Cells 63 ThGRF 63 Abiraterone acetate 63 LE DT 63 vidofludimus 63 encapsulates siRNAs 63 ALN TTR# 63 Intravenous CP 63 ZADAXIN ® 63 LEX System 63 Tarvacin TM 63 Cardio Vascu Grow 63 tafamidis 63 recombinant subunit vaccine 63 GRN#L 63 MyVax R 63 pomalidomide 63 Quinamed 63 Virulizin R 63 virus HCV protease inhibitor 63 generation URAT1 inhibitor 63 Lixivaptan 63 RNAi therapeutic targeting 63 IMC #B 63 candidate AQ4N 63 TELCYTA 63 DPX Survivac 63 CoFactor 63 Excellarate 63 systemically administered 63 oral picoplatin 63 Phase #/#a trial 63 oral taxane 63 epothilone 63 SparVax TM 63 hyaluronidase rHuPH# 63 Onalta 63 INT# [002] 63 sodium Injection 63 Tarsa oral calcitonin 63 LymphoStat B 63 Chemokine Therapeutics 63 efaproxiral 63 Neuradiab 63 CB2 selective receptor agonist 63 PDX pralatrexate 63 molecular imaging radiopharmaceutical 63 ENMD # 63 Octreotide 63 VALSTAR 63 R sorafenib tablets 63 HDL Mimetic Peptide 63 Aurexis 63 therapeutic monoclonal antibodies 63 LEP ETU 63 OvaRex ® MAb 63 oral ridaforolimus 63 Panzem 63 OncoVEX 63 epothilones 63 ganetespib 63 IAP inhibitors 63 TACI Ig 63 preclinically 63 Lisofylline LSF 63 Varespladib 63 NeuVax 63 radiation sensitizer 63 LymphoStat B TM 63 ionotropic glutamate receptor antagonists 63 SERMs 63 TYZEKA 63 antisense drug 63 Trofex 63 Hsp# inhibitor 63 next generation URAT1 63 Angiocept 63 UVIDEM 63 YONDELIS 63 Viprinex TM 63 Neo Kidney Augment ™ 63 LEUKINE 63 Elesclomol 63 trastuzumab DM1 T DM1 63 HGS ETR1 mapatumumab 63 Locteron 63 Dalbavancin 63 OXi# 63 Elagolix 63 VEGF Trap 63 bortezomib Velcade 62 SPC# [001] 62 PREOS R 62 Soliris eculizumab 62 Alzhemed TM 62 StaphVAX R 62 IAP inhibitor 62 PHX# 62 Prodarsan R 62 TRO# 62 OHR/AVR# 62 Inhalation Solution 62 glucagon receptor 62 refractory gout 62 teduglutide 62 Factor IX 62 MT#/MEDI-# 62 TG# [003] 62 Diamyd ® 62 glucokinase activator 62 ORENCIA R 62 IND submission 62 Pimavanserin 62 Aganocide 62 PROVENGE sipuleucel T 62 protein tyrosine phosphatase 1B 62 A1PI 62 Nanobody ® 62 Phase 2a trial 62 AQ4N 62 LymphoStat B belimumab 62 CYT# potent vascular disrupting 62 Besivance 62 orally bioavailable 62 ELADUR 62 Tezampanel 62 OTCBB HXBM developer 62 eniluracil 62 angiogenesis inhibitor 62 AzaSite Plus 62 inhaled formulation 62 MYDICAR 62 L DOS# 62 Tarmogen 62 MKC# MT 62 HuCAL antibodies 62 dacetuzumab 62 Aloxi injection 62 XL# XL# XL# XL# 62 PANVAC VF 62 torsemide ER 62 candidate TNFerade biologic 62 compound INCB# 62 ATL# [001] 62 cannabinor 62 BAY #-# 62 ONTAK 62 RiVax 62 Virulizin ® 62 Iluvien ® 62 Factor VIIa 62 E2F Decoy 62 Proellex TM 62 tiapamil 62 SLx 62 OMP #M# 62 Vidofludimus 62 atacicept 62 Nexavar ® 62 LHRH antagonists 62 Locteron ® 62 CINTREDEKIN BESUDOTOX 62 Technosphere Insulin 62 Cloretazine R VNP#M 62 Aviptadil 62 Civacir 62 talactoferrin 62 motexafin gadolinium Injection 62 RenaZorb TM 62 octreotide implant 62 leading oral taxane 62 Ozarelix 62 mitogen activated ERK kinase 62 Phase #b/#a 62 SparVax ™ 62 oncolytic virus therapies 62 Telintra 62 sapacitabine CYC# 62 Omigard 62 ridaforolimus 62 XP# XP# 62 mGluR5 NAM 62 Cloretazine ® 62 candidate NGX 62 CCR9 antagonist 62 Campath ® 62 hyaluronidase enzyme 62 intranasal formulation 62 Curaxin CBLC# 62 preclinical toxicology 62 OMP #R# 62 acetonide FA 62 faropenem medoxomil 62 tolevamer 62 Bicifadine 62 proteasome inhibitor 62 Ixempra 62 Ophena 62 novel L DOS# 62 corticosteroid dexamethasone 62 CytoFabTM 62 Zemiva TM Trofex TM 62 non porcine pancreatic 62 non nucleoside inhibitor 62 PRX # 62 Syncria 62 Tyrima 62 Nexavar sorafenib 62 Relivar 62 TRAIL receptor antibodies 62 Ocrelizumab 62 candidate ridaforolimus 62 systemic immunosuppressive drugs 62 Protexia R 62 Allovectin 7 R 62 BRAF kinase 62 Cannabinor 62 CR# vcMMAE 62 Cand5 62 candidate epratuzumab 62 Spiegelmer ® 62 BIM #A# 62 GLP toxicology studies 62 Litx 62 rxRNA 62 deforolimus 62 recombinant biopharmaceutical 62 MLN# 62 oral proteasome inhibitor 62 Menerba 62 Thiarabine 62 RGB # 62 systemic RNAi therapeutic 62 atrasentan 62 PEGylation technology 61 BioVant 61 CTA# Injection 61 ancrod 61 Vicriviroc 61 FOLOTYN ® 61 docetaxel Taxotere R 61 R#/MEM 61 aleglitazar 61 selective inhibition 61 PDE4 inhibitors 61 orally bioavailable mimics 61 Phase 2a clinical 61 Epanova 61 Phase Ib clinical trials 61 NPC 1C 61 generation Hsp# inhibitor 61 Oral NKTR 61 CRMD# 61 hA# 61 Tesetaxel 61 DAVANAT R 61 PRTX 61 Amrubicin 61 otelixizumab 61 Alnylam #x# 61 THALOMID 61 AAG geldanamycin analog 61 Gemzar ® 61 JVRS 61 APF# 61 DAVANAT 61 SUCCEED trial 61 MGd 61 ZEGERID Capsules 61 Thalomid ® 61 Dyloject TM 61 Posiphen 61 pertuzumab 61 Kamada AAT 61 PTH analogue 61 humanized monoclonal antibodies 61 registrational trial 61 Phase IIb trials 61 Tarceva TM 61 P2V TM 61 midstage trials 61 Fibrillex TM 61 targets Galectin receptors 61 Tasimelteon 61 NEBIDO 61 QNEXA ® 61 TPI ASM8 61 CRLX# 61 Plenaxis TM 61 Phase #b/#a trial 61 RSD# oral 61 DXL# 61 PRX# 61 zileuton CR 61 5 HT3 antagonist 61 Zorbtive TM 61 Zerenex 61 Intermezzo ® zolpidem tartrate 61 Onalta ™ 61 Atrasentan 61 AERx ® 61 candidate deforolimus 61 Traficet EN 61 platinum chemotherapeutic 61 Icatibant 61 Daclizumab 61 hypoxia activated prodrug 61 dosing cohort 61 IMP# 61 Stimuvax R 61 renin inhibitors 61 inhaled AAT 61 ARIKACE ™ 61 lumiliximab 61 BrachySil TM 61 TAT# 61 reslizumab 61 Apo AI 61 IMiDs 61 mesylate tablets 61 OMNARIS HFA 61 trodusquemine MSI 61 Neo Urinary Conduit 61 EOquin TM 61 ruxolitinib 61 phase IIb study 61 LNP formulations 61 oral methylnaltrexone 61 glufosfamide 61 Telatinib 61 sitaxsentan 61 Amplimexon 61 sodium thiosulfate STS 61 TKM Ebola 61 aldehyde dehydrogenase ALDH2 deficiency 61 including eniluracil ADH 61 HIV maturation inhibition 61 TransVax TM 61 PEGylated Fab fragment 61 Dasatinib 61 trastuzumab Herceptin R 61 Vandetanib 61 GED aPC 61 maximally tolerated dose 61 drug conjugate 61 NEUMUNE 61 TNF Tumor Necrosis Factor 61 candidate REP# 61 cobiprostone 61 CA4P 61 VA# [002] 61 docetaxel chemotherapy 61 Allovectin 7 r 61 Sulonex TM 61 Synavive 61 docetaxel Taxotere ® 61 USL# 61 selective modulator 61 Lisofylline 61 budesonide foam 61 Fodosine 61 systemic RNAi 61 MGCD# [001] 61 DermaVir Patch 61 Leukine ® 61 TELINTRA R 61 lapatinib Tykerb 61 riociguat 61 NEUGENE 61 GGF2 61 lipid nanoparticle 61 Amigal 61 dasatinib Sprycel 61 Neo Kidney Augment 61 telomerase therapeutic 61 LE SN# 61 incyclinide 61 delivers fluocinolone acetonide FA 61 MyVax ® 61 EXPAREL TM 61 ATL# [002] 61 Altastaph 61 FOLFOX6 chemotherapy regimen 61 PNT# 61 dose cohort 61 ATryn ® 61 torezolid phosphate 61 ANAVEX #-# [001] 61 tanespimycin 61 humanized anti 61 novel histone deacetylase 61 oral salmon calcitonin 61 confirmatory Phase III 61 hormone agonist 61 ocular formulation 61 PEGylated interferon 61 T Pred 61 #D#C# 61 Cloretazine VNP#M 61 Seliciclib 61 HCV protease inhibitors 61 telaprevir VX 61 Aflibercept 61 #ME# 61 proprietary transdermal patch 61 cediranib 61 ProSavin 61 L BLP# 61 INKP 61 registrational 61 MTP inhibitor 61 PrevOnco ™ 61 vascular disrupting agents 61 orally dosed 61 PEGylated 61 renin inhibitor 61 plasmid DNA vaccine 61 ATL/TV# 61 Lenocta 61 product candidate Lpathomab 60 Tekamlo 60 ALK inhibitor 60 orBec 60 RNA antagonist 60 Tumour Vascular Disrupting Agent 60 ALGRX 60 Aurora kinase inhibitor 60 Aptivus ® 60 Arikace 60 CIMZIA TM 60 Surfaxin LS 60 subcutaneous formulation 60 Marqibo TM 60 GAP #B# 60 sumatriptan DosePro 60 evaluating satraplatin 60 personalized cellular immunotherapy 60 Hematide TM 60 Medarex UltiMAb R 60 Tocosol Paclitaxel 60 methylnaltrexone bromide 60 Exherin TM 60 sorafenib Nexavar 60 Familial Adenomatous Polyposis FAP 60 apricitabine ATC 60 RNAi therapeutic 60 investigational pan BCR 60 lexidronam injection 60 REGN# 60 Solazed ™ 60 obatoclax 60 2 methoxyestradiol 60 personalized immunotherapy 60 NVA# 60 rPA anthrax vaccine 60 PROSTASCINT R 60 phase IIb trial 60 IV APAP 60 pan HDAC inhibitor 60 Muraglitazar 60 IV Busulfex 60 selectively inhibit 60 Pertuzumab 60 eprotirome 60 EndoTAG TM 60 romidepsin novel 60 HDL Selective Delipidation 60 AEGR 60 Aztreonam lysine 60 Naproxcinod 60 ONCONASE R 60 Velcade bortezomib 60 ICA # 60 elacytarabine 60 pitavastatin 60 Liprotamase 60 HCD# [002] 60 HEPLISAV TM 60 TREANDA 60 QLT# 60 cMET 60 trial evaluating PRX# 60 Anturol 60 HuMax CD4 60 Insegia 60 visilizumab 60 OnDose TM 60 PREGNANT Study 60 HuCNS SC ® 60 Sudhir Agrawal D.Phil 60 intranasal insulin 60 liposomal delivery 60 doxercalciferol 60 Phase 1a clinical 60 JZP 60 accumulate preferentially 60 vinca alkaloid 60 Aganocide ® 60 Curaxin 60 Temsirolimus 60 HuMax TAC 60 cetuximab Erbitux ® 60 teriflunomide 60 ALN HPN 60 tezampanel 60 MAP# 60 ELND# 60 ProLindac 60 H#N# VLP vaccine 60 AeroLEF R 60 hormone LHRH antagonist 60 busulfan 60 recombinant polyclonal antibody 60 NV1FGF 60 Riquent 60 lixivaptan 60 vernakalant oral 60 xanthine oxidase inhibitor 60 KRN# 60 enzastaurin 60 XmAb# 60 mGluR2 NAM 60 adecatumumab MT# 60 PEG Interferon lambda 60 sipuleucel T 60 humanized monoclonal antibody 60 S1P antibody 60 Tekmira SNALP technology 60 Topical Interferon Alpha 2b 60 Squalamine 60 GRN# 60 DepoVax ™ 60 rFVIIIFc 60 hyperphenylalaninemia HPA due 60 Valortim ® 60 agonistic human 60 IMiDs R 60 histone deacetylase HDAC 60 rNAPc2 60 Exelixis compounds 60 histone deacetylase HDAC inhibitor 60 NYSE Amex PTN 60 COREG CR 60 Aerosurf 60 AMD# [002] 60 pseudobulbar affect PBA 60 ChronVac C R 60 ZALBIN 60 protein kinase inhibitor 60 Ostarine 60 INTEGRILIN 60 Dextofisopam 60 Hectorol R 60 rhIL 7 60 investigational immunotherapy 60 sodium glucose cotransporter 60 investigational pharmacologically unique 60 TransVax tm 60 generation purine nucleoside 60 TPIAO 60 Saforis 60 DexaSite 60 Phenserine 60 Reverset 60 RECOTHROM R 60 PEG PAL 60 tubulin inhibitor 60 Phase III Pivotal 60 Proxinium TM 60 Unit Dose Budesonide 60 PhG alpha 1 60 investigational compounds 60 Omacetaxine 60 Pruvel 60 ILUVIEN ® 60 HuMax EGFr 60 TAKSTA 60 Capesaris 60 ZOLINZA 60 ISTODAX 60 Ascend Therapeutics 60 SIMCOR 60 SAR# [004] 60 CINQUIL 60 SPRYCEL ® 60 sargramostim 60 rhThrombin 60 EFAPROXYN 60 lesinurad 60 Tarvacin 60 preclinical studies 60 velafermin belinostat 60 potency selectivity 60 proprietary PEGylation 60 TOCOSOL 60 squalamine 60 Azedra TM Onalta TM 60 XL# XL# 60 muscarinic receptor agonist 60 C1 INH 60 OvaRex 60 Telbivudine 60 interferon gamma 1b 60 prophylactic vaccine 60 oral deforolimus 60 albiglutide 60 rHuPH# enzyme 60 EVIZON TM squalamine lactate 60 Saxagliptin 60 JAK3 60 bicifadine 60 pralatrexate 60 GVAX R 60 omega interferon 60 punctal plug 60 velafermin 60 pharmacological chaperone 60 Corlux 60 trastuzumab DM1 60 forodesine hydrochloride 60 ponatinib 60 SIRT1 activators 60 aflibercept 60 alkylating agent 60 candidate EFAPROXYN TM 60 VIAtab TM 60 erlotinib Tarceva ® 60 IMiDs ® 60 eTag assays 60 PF # [002] 60 lucinactant 60 midstage clinical 60 Cloretazine 60 candidates Azedra 60 Oncaspar 60 human IgG1 monoclonal 60 TH# [003] 60 oncolytic 60 carbohydrate polymer 60 DCVax ® 60 Numax 60 ESTRASORB 60 Phase Ib study 60 SNALP 60 phase III isavuconazole 60 selective androgen receptor modulators 60 DAVANAT ® 60 Rebif ® 60 oncolytic virus 60 DCCR 60 Maribavir 60 biologic therapeutics 60 DPP4 inhibitor 59 volociximab 59 Fleximer 59 Shigamabs R 59 Anturol TM 59 nanoviricides 59 CORLUX 59 gamma secretase inhibitor 59 selective immunoproteasome inhibitor 59 Filgrastim 59 cathepsin K inhibitor 59 lenalidomide Revlimid R 59 inecalcitol 59 anticancer agent 59 immune modulatory 59 candidate CRLX# 59 ARIKACE 59 Aurora kinase 59 EZN 59 fenofibric acid 59 Zolinza 59 antibody MAb 59 treat lupus renal 59 interferon beta 59 anionic backbone 59 MCSP respectively 59 ospemifene 59 teplizumab 59 bafetinib 59 Tykerb lapatinib 59 Oracea TM 59 Actimmune ® 59 Fludara ® 59 Jevtana 59 ularitide 59 OMS#HP 59 Arcalyst 59 mda 7 59 pegfilgrastim 59 PGL# 59 targeted antifolate 59 Ketotransdel 59 successfully commercialize Iluvien 59 Celacade TM technology 59 GW# [003] 59 CDK inhibitor 59 nicotinic alpha 7 59 Tekturna HCT 59 Shigamabs ® 59 CAMBRIDGE Mass. Alnylam Pharmaceuticals 59 immunotoxins 59 rALLy clinical trial 59 Ethyol 59 multi kinase inhibitor 59 XL# anticancer compounds 59 modified glutathione analog 59 monoclonal antibody conjugated 59 ZEVALIN ® 59 Somatuline ® 59 GALNS 59 darapladib 59 JAK inhibitors 59 Zytiga 59 DCVax R 59 cinacalcet HCl 59 oncolytic virus therapy 59 microtubule inhibitor 59 Urokinase 59 Human cl 59 isoform selective 59 Empatic TM 59 nanoviricide drug 59 AN# novel 59 Pentad TM 59 AdhTAP 59 adenovector 59 TLR9 agonist 59 Cintredekin Besudotox 59 proprietary BiTE ® 59 lead molecular radiotherapeutic 59 Xanafide 59 compound AEOL # 59 luteinizing hormone releasing 59 Theratope 59 Talabostat 59 lorvotuzumab mertansine 59 transdermal spray 59 BYETTA ® 59 Zenvia ™ 59 GelSite R polymer 59 ATRA IV 59 topically applied SEPA 59 Sopherion 59 inhibit metastasis 59 RIGScan CR 59 CD3 monoclonal antibody 59 proteasome inhibitors 59 PEGylated anti 59 adecatumumab 59 RhuDex R 59 TRILIPIX 59 MDV# 59 ASG 5ME 59 L Annamycin 59 FUSILEV ® 59 clinical trials SGN 59 sulfonylurea glimepiride 59 Duromist ™ 59 dextromethorphan quinidine 59 DiLA2 59 anidulafungin 59 demonstrated antitumor activity 59 NP2 Enkephalin 59 PI3K/Akt pathway inhibitor 59 phase IIa 59 Valortim R 59 DURIN TM 59 NeuroVax TM 59 Actimmune R 59 bucindolol hydrochloride 59 Evoltra ® 59 topical gel containing 59 Survivin antagonist 59 ASONEP TM 59 AP# [003] 59 Apoptone 59 rFIXFc 59 Actilon 59 Initiate Clinical Trial 59 Peginterferon alfa 2b 59 Enkephalin 59 telomerase inhibitor drug 59 Phase Ib II 59 delivery polymer matrix 59 TLR8 agonist 59 PD LID 59 Empatic ™ 59 Phase IIIb clinical 59 urocortin 2 59 daclizumab 59 AMD# [003] 59 dacetuzumab SGN 59 Genz # 59 Phase Ib 59 MAA submission 59 assessing T DM1 59 novel peptide 59 Alvesco R 59 opioid induced bowel dysfunction 59 EndoTAG 59 RAPTIVA R 59 pivotal bioequivalence 59 SEPET TM 59 ESTRASORB R 59 Degarelix 59 Davanat 59 Cobalamin 59 anticoagulant reversing agent 59 SCIB1 59 Evamist TM 59 novel anticancer 59 include PLX IBD 59 TÎ ² 4 59 Ostabolin C 59 sapacitabine 59 LungExpress Dx TM 59 prostone 59 Plicera 59 LHRH antagonist 59 histamine dihydrochloride 59 Nanobody R 59 siRNA therapeutics 59 Sorafenib Nexavar 59 VNP#M 59 anticancer activity 59 LibiGel ® 59 oral beclomethasone dipropionate